EGI
IDYA icon

EAM Global Investors’s IDEAYA Biosciences IDYA Stock Holding History

EAM Global Investors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-68,778
Closed -$1.44M – 214
2021
Q2 		$1.44M Sell
68,778
-23,531
-25% -$483K 0.4% 136
2021
Q1 		$2.17M Buy
+92,309
New +$1.78M 0.6% 97
2020
Q4 		– Sell
-95,106
Closed -$1.2M – 153
2020
Q3 		$1.2M Hold
95,106
– – 0.44% 115
2020
Q2 		$1.35M Buy
+95,106
New +$749K 0.61% 83

Other funds holding IDYA

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

EAM Global Investors's IDYA Position: Q3 2021 in Review

EAM Global Investors sold out of IDEAYA Biosciences (IDYA) in Q3 2021, closing a stake of 68,778 shares — an estimated $1.44M sold.

EAM Global Investors first reported a position in IDYA in Q2 2020 and held it in 4 quarters. The position peaked at $2.17M in Q1 2021. 91 funds tracked by Wall St. Rank hold IDYA as of Q3 2021.

  • EAM Global Investors reported no remaining IDEAYA Biosciences position as of Q3 2021 after selling out during the quarter.
  • EAM Global Investors sold 68,778 IDEAYA Biosciences shares in Q3 2021, an estimated $1.44M.
  • EAM Global Investors first reported a position in IDEAYA Biosciences in Q2 2020 and held it in 4 quarters.
  • EAM Global Investors's IDEAYA Biosciences position peaked at $2.17M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2021.

Based on EAM Global Investors's 13F filing for Q3 2021, filed 12 Nov 2021.